UK markets close in 7 hours 46 minutes

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.12+0.67 (+15.06%)
At close: 04:00PM EST
5.09 -0.03 (-0.59%)
After hours: 07:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.45
Open4.55
Bid0.00 x 1000
Ask0.00 x 900
Day's range4.49 - 6.07
52-week range1.99 - 30.50
Volume3,480,676
Avg. volume65,111
Market cap48.472M
Beta (5Y monthly)1.36
PE ratio (TTM)N/A
EPS (TTM)-21.73
Earnings date14 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.00
  • Business Wire

    TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

    BOCA RATON, Fla., December 04, 2022--TherapeuticsMD, Inc. (NASDAQ: TXMD) ("TherapeuticsMD," "TXMD" or the "Company"), an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements to license its products to an affiliate of Mayne Pharma Group Limited ("Mayne Pharma"), an ASX-listed specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals, for commercialization in the United States. In addition, TXMD has agree

  • Zacks

    TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates

    TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -53.43% and 30.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    TherapeuticsMD Announces Third Quarter 2022 Financial Results

    BOCA RATON, Fla., November 14, 2022--TherapeuticsMD, Inc. ("TXMD" or the "Company") (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the third quarter ended September 30, 2022.